Tanım

The global in vitro diagnostics market in terms of revenue is set to grow by US$ 27 sırasında milyar 2021-2027, yıllık bileşik büyüme oranında büyüyor (CAGR) ile ilgili 5.4% tahmin dönemi boyunca, veri ve analiz şirketi StratejiHelix'e göre. Growth in the geriatric population, increasing prevalence of chronic and infectious diseases, rising demand for in-vitro diagnostics during COVID-19 pandemic are the key factors driving market growth.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2017-2020 ve tahmin 2027 covering key market aspects like sales value for in vitro diagnostics. The global in vitro diagnostics market is segmented on the basis of product, technique, başvuru, region, and end user. Ürüne göre, it is categorized into instruments, reagents, and software & services. The reagents segment held the largest market share in 2020. By technique, the in vitro diagnostics market is divided into immunodiagnostics, poc testing, molecular diagnostics, hematology, tissue diagnostics, and clinical chemistry. İçinde 2020, the immunodiagnostics segment held the largest share of the market, and the molecular diagnostics segment is anticipated to register the highest CAGR during 2021 ile 2027. Based on application, the in vitro diagnostics market is divided into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, ve diğerleri. In vitro diagnostics market by region is divided into North America, Asya Pasifik, Avrupa, and Rest of the World (ROW).

The report has profiled some of the key players of the market such as Abbott Laboratories, Alere Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Ortho-Clinical Diagnostics Inc. (Carlyle Group), Panasonic Healthcare Holdings Co. Ltd.. (Bayer AG), QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen Group.

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the in vitro diagnostics market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Ürün: instruments, reagents, and software & services
Technique: immunodiagnostics, poc testing, molecular diagnostics, hematology, tissue diagnostics, and clinical chemistry
Başvuru: infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, ve diğerleri
End user: hospitals, laboratories, homecare, ve diğerleri
Bölge: Kuzey Amerika, Asya Pasifik, Avrupa, and Rest of the World (ROW)
Düşünülen Yıllar: bu rapor dönemi kapsamaktadır 2017 ile 2027

Paydaşlar için Temel Faydalar

Get a comprehensive picture of the global in vitro diagnostics market
Identify regional strategies and strategic priorities on the basis of local data and analysis
Büyüme sektörlerini ve yatırım eğilimlerini belirleyin
Understand what the future of the global in vitro diagnostics market looks like
Rekabet ortamını ve fırsat penceresini belirleyin

İçindekiler

1. Pazar Tanımı
2. Araştırma Metodolojisi
3. Piyasa verileri & Görünüm
3.1 Market değeri
3.2 Piyasa Değeri Tahmini
4. In Vitro Diagnostics Market by Product
4.1 Instruments
4.2 Reagents
4.3 Software & Hizmetler
5. In Vitro Diagnostics Market by Technique
5.1 Immunodiagnostics
5.2 Poc Testing
5.3 Molecular Diagnostics
5.4 Hematology
5.5 Tissue Diagnostics
5.6 Clinical Chemistry
6. In Vitro Diagnostics Market by Application
6.1 Infectious Diseases
6.2 Cancer
6.3 Cardiac Diseases
6.4 Immune System Disorders
6.5 Nephrological Diseases
6.6 Gastrointestinal Diseases
6.7 Diğerleri
7. In Vitro Diagnostics Market by Region
7.1 Kuzey Amerika
7.2 Asya Pasifik
7.3 Avrupa
7.4 Rest Of The World (Row)
8. In Vitro Diagnostics Market by End User
8.1 Hastaneler
8.2 Laboratories
8.3 Homecare
8.4 Diğerleri
9. Şirket profilleri
9.1 Abbott Laboratories
9.2 Alere Inc.
9.3 Beckman Coulter Inc. (Danaher Corporation)
9.4 Becton, Dickinson and Company
9.5 Biomerieux SA
9.6 Bio-Rad Laboratories, A.Ş..
9.7 F. Hoffmann-La Roche Ltd
9.8 Ortho-Clinical Diagnostics, A.Ş.. (Carlyle Group)
9.9 Panasonic Healthcare Holdings Co., Ltd.. (Bayer AG)
9.10 QIAGEN N.V.
9.11 Siemens Healthineers AG
9.12 Sysmex Corporation
9.13 Thermo Fisher Scientific Inc.
9.14 Werfen Group
10. Ek
10.1 StratejiHelix Hakkında
10.2 Sorumluluk reddi beyanı